ANNUAL REPORT FOR THE YEAR ENDED 12-31-08

Company

Raphael Pharmaceutical Inc.

Filed

March 27, 2009

Period of Report

December 31, 2008

Accession Number

0001165527-09-000198

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →